Modelos de datos seleccionados

Debe iniciar sesión para seleccionar modelos de datos para descargar o realizar un análisis.

7 Resultados de la búsqueda.
Relevancia Evaluación Nuevo primero Antiguo primero

Pancreatic Cancer NCT00058149 Response - E6201 Cover Page for Supplemental Form - 2075318v3.0 - E6201 Cover Page for Supplemental Form

- 09/01/2015 - 1 formulario, 4 itemgroups, 12 items, 1 idioma
Itemgroups: Header, On Treatment, Off Treatment, CCRR MODULE
E6201 Cover Page for Supplemental Form A Phase III, Randomized Study of Gemcitabine (Fixed-Dose Rate Infusion) and Oxaliplatin (NSC 266046) Versus Gemcitabine (Fixed-Dose Rate Infusion) Versus Gemcitabine (30-Minute Infusion) in Pancreatic Carcinoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B1B0ADEE-BA19-4B20-E034-0003BA12F5E7

Pancreatic Cancer NCT00058149 Response - E6201 Cover Page for Adverse Event Form - 2075284v3.0 - E6201 Cover Page for Adverse Event Form

- 09/01/2015 - 1 formulario, 4 itemgroups, 12 items, 1 idioma
Itemgroups: Header, On Treatment, Off Treatment, CCRR MODULE
E6201 Cover Page for Adverse Event Form A Phase III, Randomized Study of Gemcitabine (Fixed-Dose Rate Infusion) and Oxaliplatin (NSC 266046) Versus Gemcitabine (Fixed-Dose Rate Infusion) Versus Gemcitabine (30-Minute Infusion) in Pancreatic Carcinoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B1B0ABAE-0BB9-4B1E-E034-0003BA12F5E7

Pancreatic Cancer NCT00058149 Response - E6201 Cover Page for RECIST Forms - 2075205v3.0 - E6201 Cover Page for RECIST Forms

- 09/01/2015 - 1 formulario, 4 itemgroups, 13 items, 1 idioma
Itemgroups: Header, On Treatment, Off Treatment, CCRR MODULE
E6201 Cover Page for RECIST Forms A Phase III, Randomized Study of Gemcitabine (Fixed-Dose Rate Infusion) and Oxaliplatin (NSC 266046) Versus Gemcitabine (Fixed-Dose Rate Infusion) Versus Gemcitabine (30-Minute Infusion) in Pancreatic Carcinoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B1B164EC-ED7F-4A7F-E034-0003BA12F5E7

Pancreatic Cancer NCT00058149 Response - E6201 Cover Page for Hematology/Chemistry Forms - 2075247v3.0 - E6201 Cover Page for Hematology/Chemistry Forms

- 09/01/2015 - 1 formulario, 4 itemgroups, 12 items, 1 idioma
Itemgroups: Header, On Treatment, Off Treatment, CCRR MODULE
E6201 Cover Page for Hematology/Chemistry Forms A Phase III, Randomized Study of Gemcitabine (Fixed-Dose Rate Infusion) and Oxaliplatin (NSC 266046) Versus Gemcitabine (Fixed-Dose Rate Infusion) Versus Gemcitabine (30-Minute Infusion) in Pancreatic Carcinoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B1B0A8C1-ED1A-4B19-E034-0003BA12F5E7

CALGB: SOLID TUMOR EVALUATION FORM [80303] NCT00088894

- 21/06/2015 - 1 formulario, 5 itemgroups, 20 items, 1 idioma
Itemgroups: Header, Patient demographics, TARGET LESION(S), NON-TARGET LESION(S), Footer module
CALGB: SOLID TUMOR EVALUATION FORM [80303] NCT00088894 Gemcitabine With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=D6012DD9-1E79-035F-E034-0003BA12F5E7

Nontarget Lesions Supplemental Form NCT00058149

- 03/06/2015 - 1 formulario, 4 itemgroups, 20 items, 1 idioma
Itemgroups: ECOG clinical trial administrative data, NONTARGET LESIONS:, Comments, CCRR MODULE
Nontarget Lesions Supplemental Form NCT00058149 A Phase III, Randomized Study of Gemcitabine (Fixed-Dose Rate Infusion) and Oxaliplatin (NSC 266046) Versus Gemcitabine (Fixed-Dose Rate Infusion) Versus Gemcitabine (30-Minute Infusion) in Pancreatic Carcinoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A65D5AC6-6244-4284-E034-0003BA0B1A09

Nontarget Lesions Supplemental Form NCT00057876

- 03/06/2015 - 1 formulario, 4 itemgroups, 20 items, 1 idioma
Itemgroups: ECOG clinical trial administrative data, NONTARGET LESIONS:, Comments, CCRR MODULE
Nontarget Lesions Supplemental Form NCT00057876 Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=A6238F51-F0B5-3C1D-E034-0003BA0B1A09

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial